Following successful first “New Directions in Immuno-Oncology” international conference in 2019, the second conference will focus on Therapies and Stratification in September 2021. Our intention is to bring together a broad cross-section of the community of researchers and clinicians working at the cutting edge of immuno-oncology interventions and their stratified application. The conference will cover both the immediate and longer-term prospects in the development pipeline and the means through which we might better determine effective deployment of these interventions.
Abstract submission is now open, please download the abstract form and return to email@example.com
The Monday and Tuesday sessions will be a hybrid event, with a small number of attendees in person. The Wednesday will be entirely virtual. Registration is now open.
Registration fees cover the conference on Monday 06 September and Tuesday 07 September and Wednesday 08 September 13:00 - 15:00. Workshops places are limited to 25 per workshop and attendance can be purchased additionally during checkout.
The final programme and list of speakers will be announced soon.
Beckman Coulter Life Sciences is dedicated to developing and providing advanced technologies and equipment for research and discovery to explore new treatment methods. Our products are implemented in all major areas of Life Sciences to simplify and automate existing processes in the lab.
For more information please visit www.beckman.com
Fluidigm is committed to empowering the cancer immunotherapy community with research tools to interrogate immune cell function and the tumor microenvironment with unprecedented resolution. Using proven mass cytometry and microfluidic technologies, we provide workflows to identify and characterize changes in cellular phenotypes at single-cell resolution. Engage with us a fluidigm.com
To find out more about our sponsorship opportunities please download our sponsor information pack.